ID   RWMH23s01
AC   CVCL_C1DW
SY   RWMH 23s01
DR   Wikidata; Q114312939
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/RWMH23s01_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DP ! Ff-MH09s01
OI   CVCL_C1DQ ! Ff-MH15s01
OI   CVCL_C1DR ! Ff-MH15s02
OI   CVCL_C1DS ! Ff-MH23s01
OI   CVCL_C1DT ! RWMH09s01
OI   CVCL_C1DU ! RWMH15s01
OI   CVCL_C1DV ! RWMH15s02
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
RX   PubMed=36395757; DOI=10.1016/j.medj.2022.10.003;
RA   Yoshida, Shinsuke
RA   Kato, Tomoaki M.
RA   Sato, Yoshiko
RA   Umekage, Masafumi
RA   Ichisaka, Tomoko
RA   Tsukahara, Masayoshi
RA   Takasu, Naoko
RA   Yamanaka, Shinya
RT   "A clinical-grade HLA haplobank of human induced pluripotent stem
RT   cells matching approximately 40% of the Japanese population.";
RL   Med 4:51-66.e10(2023).
//
RX   PubMed=31497180; DOI=10.1186/s41232-019-0106-0; PMCID=PMC6717959;
RA   Umekage, Masafumi
RA   Sato, Yoshiko
RA   Takasu, Naoko
RT   "Overview: an iPS cell stock at CiRA.";
RL   Inflamm. Regen. 39:17.1-17.5(2019).
//